199 related articles for article (PubMed ID: 27474129)
1. Selective activation of CB2 receptor improves efferocytosis in cultured macrophages.
Jiang L; Chen Y; Huang X; Yuan A; Shao Q; Pu J; He B
Life Sci; 2016 Sep; 161():10-8. PubMed ID: 27474129
[TBL] [Abstract][Full Text] [Related]
2. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.
Han KH; Lim S; Ryu J; Lee CW; Kim Y; Kang JH; Kang SS; Ahn YK; Park CS; Kim JJ
Cardiovasc Res; 2009 Dec; 84(3):378-86. PubMed ID: 19596672
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway.
Mai P; Tian L; Yang L; Wang L; Yang L; Li L
J Cell Physiol; 2015 Jul; 230(7):1640-50. PubMed ID: 25545473
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
5. Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.
Correa F; Mestre L; Docagne F; Guaza C
Br J Pharmacol; 2005 Jun; 145(4):441-8. PubMed ID: 15821753
[TBL] [Abstract][Full Text] [Related]
6. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
[TBL] [Abstract][Full Text] [Related]
7. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
[TBL] [Abstract][Full Text] [Related]
8. The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway.
Denaës T; Lodder J; Chobert MN; Ruiz I; Pawlotsky JM; Lotersztajn S; Teixeira-Clerc F
Sci Rep; 2016 Jun; 6():28806. PubMed ID: 27346657
[TBL] [Abstract][Full Text] [Related]
9. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis.
Freeman-Anderson NE; Pickle TG; Netherland CD; Bales A; Buckley NE; Thewke DP
J Lipid Res; 2008 Nov; 49(11):2338-46. PubMed ID: 18614816
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation.
Carlisle SJ; Marciano-Cabral F; Staab A; Ludwick C; Cabral GA
Int Immunopharmacol; 2002 Jan; 2(1):69-82. PubMed ID: 11789671
[TBL] [Abstract][Full Text] [Related]
12. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
13. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
[TBL] [Abstract][Full Text] [Related]
14. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.
Heo KS; Cushman HJ; Akaike M; Woo CH; Wang X; Qiu X; Fujiwara K; Abe J
Circulation; 2014 Jul; 130(2):180-91. PubMed ID: 25001623
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells.
Tanaka T; Doe JM; Horstmann SA; Ahmad S; Ahmad A; Min SJ; Reynolds PR; Suram S; Gaydos J; Burnham EL; Vandivier RW
J Biol Chem; 2014 Apr; 289(15):10466-10475. PubMed ID: 24570000
[TBL] [Abstract][Full Text] [Related]
16. MafB enhances efferocytosis in RAW264.7 macrophages by regulating Axl expression.
Sato M; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Nemoto T; Sato K; Nakano H; Abe S; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Kubota I
Immunobiology; 2018 Jan; 223(1):94-100. PubMed ID: 29030012
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
[TBL] [Abstract][Full Text] [Related]
18. Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.
Taylor L; Christou I; Kapellos TS; Buchan A; Brodermann MH; Gianella-Borradori M; Russell A; Iqbal AJ; Greaves DR
Sci Rep; 2015 Jun; 5():10682. PubMed ID: 26033291
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study.
Giacoppo S; Gugliandolo A; Trubiani O; Pollastro F; Grassi G; Bramanti P; Mazzon E
Eur J Histochem; 2017 Jan; 61(1):2749. PubMed ID: 28348416
[TBL] [Abstract][Full Text] [Related]
20. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
